J-F. Muir (Rouen, France)
Effects of infliximab on systemic features in patients with COPD suffering from cachexia
E. C. Creutzberg, H. J. Pennings, M. T. J. Groenen, E. F. M. Wouters (Horn, Maastricht, Netherlands)
|  |
Effects of infliximab on local and systemic inflammation in patients with COPD suffering from cachexia
E. C. Creutzberg, M. A. Dentener, H. J. Pennings, A. J. Derks, E. F. M. Wouters (Horn, Maastricht, Netherlands)
| |
Cardiohemodynamics changes in COPD patients while using blockers of AT1 receptors to angiotensin II
A. A. Lysenko, V. V. Rodionova (Dnipropetrovsk, Ukraine; Dnipropetrovsk, Turkey)
| |
COPD: not just a respiratory disease!
C. P. Subbe, G. M. Collier, E. Bedson, D. B. Menkes (Wrexham, Bangor, United Kingdom)
| |
Effects of dietary supplements on the Fischer ratio before and after pulmonary rehabilitation
H. Kubo, N. Honda, F. Tsuji, T. Iwanaga, M. Muraki, Y. Tohda (Osakasayama, Japan)
| |
Weight control during inpatient pulmonary rehabilitation
H. J. Beck, M. Gudjonsdottir, A. Jonsdottir (Mosfellsbaer, Iceland)
| |
Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia
L. V. Litskevich, I. M. Lapteva, I. G. Lantukhova, O. M. Burak (Minsk, Belarus)
| |
The results of ten-year treatment of asthma by ICS
L. V. Belenko, I. V. Leshchenko (Ekaterinburg, Russian Federation)
| |
The effect of a dry salt inhaler in adults with COPD
T. A. Cernomaz, S. G. Bolog, T. Mihaescu (Iasi, Romania)
| |
Effect of dry sodium chloride aerosol on the respiratory tract of tobacco smokers
A. V. Chervinskaya (St. Petersburg, Russian Federation)
| |
Vaccination efficacy in workers with chronic obstructive pulmonary disease (COPD)
L. A. Stepanishcheva, G. L. Ignatova, N. V. Fedosova, I. V. Grebneva, N. R. Satrutdinova (Chelyabinsk, Russian Federation)
| |
Results of unilateral lung volume reduction surgery (LVRS) in eight patients with chronic obstructive pulmonary disease (COPD)
P. Bielen, A. Nowinski, J. Kolakowski, T. Orlowski, P. Sliwinski (Warsaw, Poland)
| |
Home mechanical ventilation (HMV) in chronic obstructive pulmonary disease (COPD) long term results and prognosis factors
P. de Lucas Ramos, P. Resano Barrio, S. López Martín, A. Alcorta Mesa, F. Villar Alvarez, J. M. Bellón Cano, J. M. R. González-Moro (Madrid, Spain)
| |
Different types of medical intervention and the smoking cessation rate in COPD patients
K. Gashynova, T. Pertseva, K. Bogats‘ka (Dnipropetrovs‘k, Ukraine)
| |
Integrated COPD team is useful in reducing length of stay in hospitalised COPD patients
D. K. Mukherjee, B. M. Yung, J. T. Samuel, A. M. Elsheikh, M. Ali, J. Quint, J. Creasey, S. Lincoln, Community COPD Team (Basildon, United Kingdom)
| |
Economic burdens of patients with chronic obstructive pulmonary disease (COPD) in Japan
R. Wakabayashi, K. Yamada, K. Kida (Tokyo, Japan)
| |
Development of SPIRO, a healthcare network for the management of COPD
the SPIRO Network (Pierre Benite, France)
| |
Perspectives that influence action plans in COPD
S. Costi, D. Brooks, R. Goldstein (Toronto, Canada; Modena, Italy)
| |
Prospective analysis of lung function in COPD patients – home monitoring of FEV1 and PEF (PIKO®1)
M. Guimaraes, A. Oliveira, A. Rego, N. Taveira (Porto, Portugal)
| |
A survey of asthmatics‘ opinion about the inhalational medicines
A. Soltani, D. Darvishnia (Tonekabon, Islamic Republic Of Iran)
| |
Seasonal variation in COPD exacerbations
P. Branagan, B. Lynch, A. Freyne, T. B. Low, E. McGuire, I. Sulaiman, C. Woods, S. H. Chotirmall, E. A. Neofytou, R. W. Costello (Dublin, Ireland)
| |